News – San Diego Biotechnology Network

Center for Beta Cell Therapy in Diabetes and ViaCyte Announce Start of European Clinical Trial of Human Stem Cell-derived Implants in Type 1 Diabetes Patients

January 21, 2019 sandiegobiotech Comments Off

BRUSSELS and SAN DIEGO, Jan. 21, 2019 /PRNewswire/ — The Center for Beta Cell Therapy in Diabetes, coordinator of an international consortium in translational medicine in diabetes, and ViaCyte, Inc., a privately held regenerative medicine company,… […]

Biocept Announces Pricing of $2.2 Million Registered Direct Offering

January 18, 2019 sandiegobiotech Comments Off

SAN DIEGO, Jan. 18, 2019 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC) (“Biocept” or the “Company”), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of… […]

UC San Diego Kicks Off the New Year with Changemaker Week

January 17, 2019 sandiegobiotech Comments Off

The New Year is a time of fresh starts and positive change. At UC San Diego, students, faculty and staff are celebrating this time with Changemaker Week from Jan. 20-26. The weeklong series of events will featur… […]

A Time to Step Up

January 17, 2019 sandiegobiotech Comments Off

As she navigated the pathways of a long and distinguished career in academia, Kimberley Phillips Boehm steadily became aware that one day she would need to step up and give back.
[…]

Widening the Pathway to a STEM Career

January 17, 2019 sandiegobiotech Comments Off

At the moment he was born, the odds already tilted against Gentry Patrick. The percentages said an African-American from South Central Los Angeles was not likely to become a tenured neuroscience professor at a m… […]

Mirati Therapeutics Announces Proposed Public Offering Of Common Stock

January 16, 2019 sandiegobiotech Comments Off

SAN DIEGO, Jan. 16, 2019 /PRNewswire/ — Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced that it intends to offer and sell, subject to market and other conditions, $75.0 million of shares of its common stock in an underwritten public offeri… […]

Applied Spectral Imaging (ASI) reveals advanced FISH solutions that deliver ultra-fast imaging analysis

January 16, 2019 sandiegobiotech Comments Off

CARLSBAD, Calif., Jan. 16, 2019 /PRNewswire/ — Applied Spectral Imaging (ASI), a global leader and provider of biomedical imaging analysis solutions has launched a new product update to facilitate the growing demands of pathology and cytogenetic la… […]

Neurotech Pharmaceuticals, Inc. and Lowy Medical Research Institute Announce Publication of NT-501 Phase 2 Results

January 16, 2019 sandiegobiotech Comments Off

CUMBERLAND, R.I. and LA JOLLA, Calif., Jan. 16, 2019 /PRNewswire/ — The results of the NT-501 Phase 2 study sponsored by Neurotech Pharmaceuticals, Inc. (Neurotech) in collaboration with the Lowy Medical Research Institute (LMRI), have been publish… […]

Phoenix Molecular Designs Announces Collaboration To Develop Diagnostic for Triple-Negative Breast Cancer

January 16, 2019 sandiegobiotech Comments Off

-Diagnostic can detect activated RSK2, a prime target in TNBC, in breast cancer patients-

VANCOUVER, British Columbia and SAN DIEGO, Jan. 16, 2019 /PRNewswire/ — Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing… […]

Trovagene Announces Adjournment of Special Meeting of Stockholders Until February 12, 2019

January 15, 2019 sandiegobiotech Comments Off

SAN DIEGO, Jan. 15, 2019 /PRNewswire/ — Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, taking a precision cancer medicine approach to develop drugs that target cell division (mitosis) for the treatment of leukemias,… […]